Resource Logo
NLM AIDSLINE

Seroepidemiology of the infection HIV in Bolivia.




 

Int Conf AIDS. 1990 Jun 20-23;6(2):436 (abstract no. 3136). Unique

OBJECTIVE: Evaluation of the seroprevalence of HIV in Bolivia. METHODS: The epidemiological vigilance begins since October 1985, and this work demonstrates the obtained results to December 1989. In the beginning it has being received the cooperation of the following countries, Venezuela (CECOIC), Peru (NAMDIA), Brazil (FIOCRUZ), Chile (UNIVERSITY OF CHILE), and Italy. Since February 1988 we made ELISA in Bolivia (INLASA, IBBA, CENETROP), for ELISA we use Wellcozyme HTLV-III, VIRGO ELECTRONUCLEONICS USA, PHARMACIA HIV1+2 COMBI, Hemagglutination Test (RETROCELL ABBOTT), Latex agglutination RECOMBIGEN and fast test HIVCHECK 1+2 DUPONT, had to confirm WESTERN BLOT DUPONT. MATERIAL: 8500 prisoners, 6830 prostitutes, 4100 blood bank. 1300 spontaneous demand, 360 prenatal control, 690 homo/bisexuals, 460 drug users, 830 army recruits, 120 policemen, 300 university students, 132 travelers, 23602 Total. RESULTS: Positive Tests confirmed by WESTERN BLOT were 23 persons, 11 from these persons have developed AIDS, all male homo/bisexuals, 7 dead, 3 returned to their country and one is under control. From 12 infected one is female, the infection was 10 by sexual relationship and 2 by blood transfusion with one of these dead by surgical complication, 6 were foreigners and returned to their native countries and 5 are under medical control. CONCLUSION: The epidemiological vigilance of HIV must be continued to obtain more dates and the true situation.

Blotting, Western Bolivia/EPIDEMIOLOGY Female Human HIV Infections/TRANSMISSION *HIV Seroprevalence Male Risk Factors ABSTRACT



 




Information in this article was accurate in December 30, 1990. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.